Sientra (SIEN) sells its breast implants and breast tissue expanders, or Breast Products, exclusively to board-certified and board-admissible plastic surgeons and tailor its customer service
Three new IPOs for Oct 27 wk, Including Shell Midstream Full IPO calendar & reports HERE In order of largest IPO first. (1) Based in Houston, TX,Shell
To understand Thursday’s Supreme Court ruling in the Association for Molecular Pathology vs. Myriad Genetics case, it helps to have an idea of how the Court has traditionally approached the
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands' OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.
| Website: | www.sientra.com |
| Email: | IR@sientra.com |
| Main Phone: | +1 805 562-3500 |
| Address: | 420 South Fairview Avenue |
| Address 2: | Suite 200 |
| State: | CA |
| City / Town: | Santa Barbara |
| Country: | US |
| Postal Code: | 93117 |
| Exchange: | NGS |
| CEO: | Ronald Menezes |
| Employees: | 255 |
| NAICS: | In-Vitro Diagnostic Substance Manufacturing(325413) |
Sientra (SIEN) sells its breast implants and breast tissue expanders, or Breast Products, exclusively to board-certified and board-admissible plastic surgeons and tailor its customer service
Three new IPOs for Oct 27 wk, Including Shell Midstream Full IPO calendar & reports HERE In order of largest IPO first. (1) Based in Houston, TX,Shell
To understand Thursday’s Supreme Court ruling in the Association for Molecular Pathology vs. Myriad Genetics case, it helps to have an idea of how the Court has traditionally approached the
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
